Re:Bayer CEO: Nexavar cancer drug is for "western patients w...
by maxerickson on Thursday January 23, 2014 @06:22PM
(#7112190)
That article is about promotional budgets, which is at least subtly different than advertising budgets. For instance, it includes $15.9 billion in samples (which are certainly promotional, but giving patients free drugs does not immediately jump to mind when you say advertising).
The number there is from the figure here:
http://www.plosmedicine.org/article/info:doi/10.1371/journal...
Re:Bayer CEO: Nexavar cancer drug is for "western patients w...
by btian on Thursday January 23, 2014 @05:55PM
(#7112012)
Do you mind explaining what's wrong with having advertising budgets? Remember that investment into marketing is tested with the same yardstick as R&D investments - revenue generated per dollar invested. If marketing isn't effective then it won't be done.
Re:Bayer CEO: Nexavar cancer drug is for "western patients w...
by warfangle on Thursday January 23, 2014 @06:32PM
(#7112253)
Keep in mind that marketing drugs is a purely American thing; in most other countries with sane healthcare policies you can market awareness of a condition but not a drug to treat the condition. Doctors should be the one helping a patient decide which medication is best for their situation, not some ad exec.
When R&D budgets are no longer superseded by advertising budgets at pharmaceutical firms[1], I will start to find this line of argument compelling.
[1] http://www.sciencedaily.com/releases/2008/01/080105140107.ht...